In a recent Healio exclusive, Kelly Cushing-Damm, MD, MSCI, discussed emerging strategies for monitoring inflammatory bowel disease (IBD) that could…
Browsing: Hot headlines in GI
A study presented at the Crohn’s & Colitis Congress revealed a significant increase in the cost of treating inflammatory bowel…
GI Alliance, a leading network of gastroenterology providers in the United States, has partnered with Ambience Healthcare to develop a…
A more proactive approach to colorectal cancer screening using fecal immunochemical tests resulted in high participation and detection rates across…
Cardinal Health (NYSE: CAH) has announced its definitive agreement to acquire Specialty Networks for $1.2 billion in cash. Specialty Networks…
The American College of Gastroenterology (ACG) has released a new clinical guideline to address alcohol-associated liver disease (ALD), particularly in…
In this month’s The Regueiro Report, I’d like to highlight two exciting FDA approvals for moderately to severely active ulcerative…
A team of researchers from Politecnico di Milano and Humanitas University has developed a 3D personalized model of biliary tract…
Circulating tumor DNA (ctDNA) detection has shown potential in predicting treatment outcomes for patients with colorectal cancer, according to data…
A phase 2/phase 3 clinical trial investigating the efficacy of using circulating tumor DNA (ctDNA) to guide adjuvant chemotherapy in…